These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37213190)

  • 41. Impact of implementation timing on the effectiveness of stay-at-home requirement under the COVID-19 pandemic: Lessons from the Italian Case.
    Mingolla S; Lu Z
    Health Policy; 2022 Jun; 126(6):504-511. PubMed ID: 35414473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Non-pharmaceutical Interventions on the Control of COVID-19 in Iran: A Mathematical Modeling Study.
    Nakhaeizadeh M; Eybpoosh S; Jahani Y; Ahmadi Gohari M; Haghdoost AA; White L; Sharifi H
    Int J Health Policy Manag; 2022 Aug; 11(8):1472-1481. PubMed ID: 34273920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of alternative Non-Pharmaceutical Interventions strategies for controlling COVID-19 outbreak in Bangladesh: A modeling study.
    Shimul SN; Hussain M; Faisel AJ; Hamid SA; Sultana N; Kuddus MA
    PLoS One; 2024; 19(2):e0293863. PubMed ID: 38394237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The short and long-term impact of nonpharmaceutical interventions on the prevalence of varicella in Xi'an during the COVID-19 pandemic.
    Bai Y; Shen L; Sun M; Yang Z; Chen Z; Zhai J; Xue M; Shao Z; Liu K; Zheng C
    J Med Virol; 2023 Aug; 95(8):e29020. PubMed ID: 37548166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China.
    Shen L; Sun M; Song S; Hu Q; Wang N; Ou G; Guo Z; Du J; Shao Z; Bai Y; Liu K
    J Med Virol; 2022 Jul; 94(7):3121-3132. PubMed ID: 35277880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inferring a cause-effect relationship between lockdown restrictions and COVID-19 pandemic trend during the first wave.
    Megna R
    Health Policy; 2021 Nov; 125(11):1441-1447. PubMed ID: 34607714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of face masks during vaccine roll-out in New YorkCity and impact on epidemic control.
    Raina MacIntyre C; Costantino V; Chanmugam A
    Vaccine; 2021 Oct; 39(42):6296-6301. PubMed ID: 34538699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantifying the spatial spillover effects of non-pharmaceutical interventions on pandemic risk.
    Wang K; Han X; Dong L; Chen XJ; Xiu G; Kwan MP; Liu Y
    Int J Health Geogr; 2023 Jun; 22(1):13. PubMed ID: 37286988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adaptive COVID-19 Mitigation Strategies: Tradeoffs between Trigger Thresholds, Response Timing, and Effectiveness.
    Sanstead EC; Li Z; McKearnan SB; Kao SZ; Mink PJ; Simon AB; Kuntz KM; Gildemeister S; Enns EA
    MDM Policy Pract; 2023; 8(2):23814683231202716. PubMed ID: 37841496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating the impacts of non-pharmaceutical interventions on the transmission dynamics of COVID-19 in Canada based on mobile network.
    Xue L; Jing S; Wang H
    PLoS One; 2021; 16(12):e0261424. PubMed ID: 34965272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterizing early Canadian federal, provincial, territorial and municipal nonpharmaceutical interventions in response to COVID-19: a descriptive analysis.
    McCoy LG; Smith J; Anchuri K; Berry I; Pineda J; Harish V; Lam AT; Yi SE; Hu S; Rosella L; Fine B;
    CMAJ Open; 2020; 8(3):E545-E553. PubMed ID: 32873583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.
    Singh S; Shaikh M; Hauck K; Miraldo M
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of different levels of non-pharmaceutical interventions on hand, foot and mouth disease in Guangzhou, China.
    Wu K; Ma X; Liu H; Zheng J; Zhou R; Yuan Z; Huang Z; Zhong Q; Huang Y; Zhang Z; Wu X
    BMC Public Health; 2022 Dec; 22(1):2398. PubMed ID: 36539790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interests, Motives, and Psychological Burdens in Times of Crisis and Lockdown: Google Trends Analysis to Inform Policy Makers.
    Rotter D; Doebler P; Schmitz F
    J Med Internet Res; 2021 Jun; 23(6):e26385. PubMed ID: 33999837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring the influence of human mobility factors and spread prediction on early COVID-19 in the USA.
    Zheng Z; Xie Z; Qin Y; Wang K; Yu Y; Fu P
    BMC Public Health; 2021 Mar; 21(1):615. PubMed ID: 33781260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Harnessing Artificial Intelligence to assess the impact of nonpharmaceutical interventions on the second wave of the Coronavirus Disease 2019 pandemic across the world.
    Tao S; Bragazzi NL; Wu J; Mellado B; Kong JD
    Sci Rep; 2022 Jan; 12(1):944. PubMed ID: 35042945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States.
    Qi Y; Shaman J; Pei S
    J Infect Dis; 2021 Nov; 224(9):1500-1508. PubMed ID: 34551108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in France.
    Roux J; Massonnaud CR; Colizza V; Cauchemez S; Crépey P
    Sci Rep; 2023 Feb; 13(1):1834. PubMed ID: 36725962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.